Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolytic Disease of the Newborn”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07277023
What this trial is testing

The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)

Who this might be right for
Sickle Cell Anemia
Centre Hospitalier Universitaire de la Guadeloupe 49
Not applicableStudy completedNCT06163196
What this trial is testing

The Effect of Acupressure on Pain in Children With Thalassemia

Who this might be right for
Pain
Mersin University 39
Testing effectiveness (Phase 2)Looking for participantsNCT06490627
What this trial is testing

Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Who this might be right for
Fetal HemoglobinThalassemia MajorGenetic Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 54
Not applicableStudy completedNCT03478917
What this trial is testing

Early Diagnosis of Sickle Acute Chest Syndrome Using a Combination of Plasma Bimarkers and Chest Imaging

Who this might be right for
Sickle Cell Disease (SCD)
National Heart, Lung, and Blood Institute (NHLBI) 65
Not applicableUnknownNCT01105923
What this trial is testing

Study of an Intervention to Improve Problem List Accuracy and Use

Who this might be right for
Attention Deficit Disorder With HyperactivityAsthmaCOPD+16 more
Brigham and Women's Hospital 140
Not applicableNot Yet RecruitingNCT07509996
What this trial is testing

Risk Factors Affecting Growth in Thalassemic Children at AUCH

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)
Assiut University 85
Not applicableStudy completedNCT02411396
What this trial is testing

Comparison of Patient Centered Outcomes for People With Sickle Cell Disease in the Acute Care Setting

Who this might be right for
Sickle Cell Disease
Johns Hopkins University 483
Testing effectiveness (Phase 2)Active Not RecruitingNCT05444894
What this trial is testing

EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT)

Who this might be right for
Transfusion Dependent Beta ThalassemiaHemoglobinopathiesThalassemia Major+1 more
Editas Medicine, Inc. 9
Testing effectiveness (Phase 2)Study completedNCT00349453
What this trial is testing

Study Using Deferiprone Alone or in Combination With Desferrioxamine in Iron Overloaded Transfusion-dependent Patients

Who this might be right for
Hemochromatosis
Lipomed 24
Early research (Phase 1)Ended earlyNCT04091737
What this trial is testing

CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease

Who this might be right for
Anemia, Sickle Cell
CSL Behring 1
Early research (Phase 1)Study completedNCT02567695
What this trial is testing

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Who this might be right for
Sickle Cell Disease
Global Blood Therapeutics 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490601
What this trial is testing

Long Term Beta Thalassemia Treatment: Findings From The Extension Period

Who this might be right for
Fetal HemoglobinBeta-ThalassemiaHemoglobinopathies
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 30
Early research (Phase 1)Ended earlyNCT05660265
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Who this might be right for
Hematologic DiseasesAnaemia, Sickle Cell
GlaxoSmithKline 11
Post-approval studies (Phase 4)Active Not RecruitingNCT05730205
What this trial is testing

Effects of the Contraceptive Implant in Women With Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
University of Pennsylvania 22
Not applicableStudy completedNCT03716726
What this trial is testing

Sickle Cell Anemia WE CARE

Who this might be right for
Sickle Cell Disease
Boston Medical Center 112
Not applicableLooking for participantsNCT02720679
What this trial is testing

Investigation of the Genetics of Hematologic Diseases

Who this might be right for
Bone Marrow Failure SyndromesErythrocyte DisorderLeukocyte Disorder+10 more
St. Jude Children's Research Hospital 1,716
Testing effectiveness (Phase 2)Study completedNCT02411708
What this trial is testing

Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis

Who this might be right for
Anemia, Sickle Cell
Prolong Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT01740713
What this trial is testing

Pharmacokinetic Study of Deferiprone in Paediatric Patients

Who this might be right for
Chronic Iron Overload
Consorzio per Valutazioni Biologiche e Farmacologiche 23
Testing effectiveness (Phase 2)Ended earlyNCT03733249
What this trial is testing

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Acute Myeloid (AML), ChildLymphoma, Non-Hodgkin+9 more
Bellicum Pharmaceuticals 187
Post-approval studies (Phase 4)Study completedNCT01736540
What this trial is testing

An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

Who this might be right for
Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia
Novartis Pharmaceuticals 243
Next Page